David M. Polen
Polen Capital Management
Polen Capital Management IDEXX Laboratories Inc stake
total: 588
Polen Capital Management IDXX trades
- Total transactions:
- 5
- New positions:
- 1
- Reduced:
- 4
- Held since:
- 2025 Q2
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Polen Capital Management holds 532,384 IDEXX Laboratories Inc (IDXX) shares with a market value of roughly $280.27M accounting for 2.41% of the overall portfolio. To date, the estimated cost basis is nearly $536.34 for "buy" trades and estimated average "sell" price is $589.89. Polen Capital Management first purchased IDXX in 2025 Q2, initially acquiring about 1.20M shares. Since the initial investment in IDEXX Laboratories Inc (IDXX), Polen Capital Management has made 4 more transactions.
When did Polen Capital Management buy IDEXX Laboratories Inc (IDXX)?
Polen Capital Management first invested in IDEXX Laboratories Inc (IDXX) in 2025 Q2 at the reported quarter-end price of $536.34 per share.
What's the cost basis of Polen Capital Management's IDXX stake?
The estimated cost basis for IDEXX Laboratories Inc (IDXX) stake is around $536.34 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $536.34
- Weighted AVG sell price:
- $589.89
Polen Capital Management's historical trades in IDEXX Laboratories Inc
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.41%
|
532,384
|
$526.44
|
$280,268,269
|
-23.49% (-163,427)
|
-0.6%
|
|
2026 Q1
|
2.70%
|
695,811
|
$561.89
|
$390,969,243
|
-27.56% (-264,726)
|
-0.64%
|
|
2025 Q4
|
2.78%
|
960,537
|
$676.53
|
$649,831,919
|
-14.78% (-166,610)
|
-0.37%
|
|
2025 Q3
|
2.34%
|
1,127,147
|
$638.89
|
$720,123,065
|
-5.71% (-68,278)
|
-0.13%
|
|
2025 Q2
|
1.97%
|
1,195,425
|
$536.34
|
$641,154,277
|
new
|
+1.97%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.